Similar Papers

Paper Title
Journal
Date
Author
Entinostat (SNDX-275), a Novel DAC Inhibitor, Is Highly Effective in Rituximab- [Chemotherapy]-Sensitive or Rituximab-[Chemotherapy]-Resistant Lymphomas and Has Synergistic Anti-Tumor Activity When Combined with Bortezomib.
Umeer Ashraf ... Francisco J Hernandez-Ilizaliturri
Blood | VOL. 114
Umeer Ashraf, et. al.Umeer Ashraf ... Francisco J Hernandez-Ilizaliturri
20 Nov 2009
Roswell Park researchers clarify mechanisms of novel therapy in non-hodgkin's lymphoma cells
-
Cancer Biology & Therapy | VOL. 8
--
01 Jan 2009
Abstract A50: Reprogramming of tumor-associated M2 macrophages with antisense oligonucleotide-loaded exosomes results in potent single-agent antitumor activity
Suhrut Kamerkar ... Adam Boutin
Cancer Immunology Research | VOL. 8
Suhrut Kamerkar, et. al.Suhrut Kamerkar ... Adam Boutin
01 Mar 2020
Peripheral T cells of patients with B cell non-Hodgkin's lymphoma show a shift in their memory status
Djordje Atanackovic ... Susanna Hegewisch-Becker
Leukemia Research | VOL. 29
Djordje Atanackovic, et. al.Djordje Atanackovic ... Susanna Hegewisch-Becker
16 Mar 2005
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Table of Contents
-
Annals of Oncology | VOL. 36
--
01 Jan 2025
Editorial Board
-
Annals of Oncology | VOL. 36
--
01 Jan 2025
89P Spatial analysis using MultiOmyx hyperplex assay reveals high prevalence of mature tertiary lymphoid structure (TLS) and PDL1 expression in the MSI-high colorectal carcinoma (CRC)
Q Au ... V Chizhevsky
Annals of Oncology | VOL. 35
Q Au, et. al.Q Au ... V Chizhevsky
01 Dec 2024
276MO Epidemiology, treatment (tx) patterns, and clinical outcomes of patients (pts) with locally advanced or metastatic urothelial cancer (la/mUC) in Taiwan: A retrospective cohort study
C-T Wu ... L-N Chien
Annals of Oncology | VOL. 35
C-T Wu, et. al.C-T Wu ... L-N Chien
01 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.